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SurgeryAbstract Thrombocytosis and hyperkalemia are entities which can have sinister complications in
the perioperative period and can be worrisome to the alert anesthesiologist. Hence it is good to be
aware of variants which are quite benign and need not lead to delaying of anaesthesia administra-
tion. One such case is reported to highlight this fact.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.61 year old lady was diagnosed with carcinoma colon for
which she underwent right hemicolectomy under General anes-
thesia and epidural analgesia. She was discharged after a week.
She got readmitted with burst abdomen for which she had an
emergency laparotomy. Partial dehiscence of ileocolic
anastomosis was found, repaired and the abdomen was closed.
Six weeks later she was again hospitalized for repair of
enterocutaneous ﬁstula. It was at this instance that her platelet
count was found to be elevated (6.5 lakh per mm3) and potas-
sium level was found to be high (5.5 meq/L). The ESR was
136 mm and C-reactive protein was 14.7 mg/L (normal – less
than 10 mg/L).This was diagnosed as reactive thrombocytosis
and the hyperkalemia was found to be pseudohyperkalemia.
Emergency surgery was done under General anesthesia.
Segmental resection and enterocolic anastomosis were per-
formed. The platelet count gradually reduced and normalized
in a few days time and the patient was discharged after 8 days.
Thrombocytosis is deﬁned as platelet count more than
4.5 · 109/L [1]. WHO deﬁnes thrombocytosis as platelet countmore than 6 lakhs [2]. Thrombocytosis is of 2 main types.
Primary or essential, a myeloproliferative disorder of the bone
marrow and reactive thrombocytosis. Thrombohemorrhagic
complications can occur in essential but not in reactive throm-
bocytosis [3]. Reactive thrombocytosis per se is not detrimental
in the context of malignancy, inﬂammation and infection. It is
considered to be an epiphenomenon of a systemic acute phase
reaction that is accompanied by excess of thrombopoietic
growth factors interleukin-6 and tumor necrosis factor-alpha
[4].
The common causes of reactive thrombocytosis are tissue
damage, infection, malignancy, chronic inﬂammation, iron
deﬁciency, severe exercise and other causes of acute phase
response. It is usually characterized by increased ESR and
C-reactive protein. Peripheral smear may show features to
indicate an underlying cause. If the clinical scenario is not con-
sistent with reactive thrombocytosis, a bone marrow examina-
tion is recommended to conﬁrm the diagnosis of essential
thrombocytosis [5].
Thrombocytosis results in increased release of potassium
during the clotting process. Sevastos et al., examined platelet
count and release of potassium during the clotting process
and found an average increase of 0.82 mmol/L of potassium
during the clotting process (range of platelet count: 400–
266 R. Subha, R.C. Koshy1500 · 103/mm3. In the absence of ecg changes and obvious
causes of increased potassium levels such as ARF and tumor
lysis syndrome, we should entertain the possibility of hemoly-
sis, lab error, pseudohyperkalemia and reverse pseudohyper-
kalemia. Simultaneous measurement of serum and plasma
potassium levels helps diagnose pseudohyperkalemia and
reverse pseudohyperkalemia. A serum to plasma potassium
gradient of more than 0.4 mmol/L is diagnostic of pseudohy-
perkalemia, provided that samples are collected under strict
techniques, remain at room temperature and are tested within
1 h from blood specimen collection) [6]. Reverse pseudohyper-
kalemia is when plasma potassium is falsely high, but serum
potassium is normal. This phenomenon has been reported in
samples of patients with leukemia/lymphoma [7].
The ratio between intra cellular and extracellular potassium
is approximately 40:1 and a change in the ratio as small as 2.5%
will increase the potassium concentration by 0.l meq/L.
Constituents of blood (RBC,WBC, Platelets) and skeletal mus-
cle release intracellular potassium either due to disease states or
faulty collection techniques. Other than patient factors which
include thrombocytosis red cell and white cell dyscrasias, other
causes for pseudo hyperkalemia include tourniquet, ethanol
containing antiseptics, cold temperature, time delay in sample
transport, contaminants like potassium containing intravenous
ﬂuids, potassium salts of tube additives and heparin induced
WBC lysis for reverse pseudohyperkalemia [8].
For our patient ,without knowing it to be pseudohyper-
kalemia, we had started potassium lowering treatment with
intravenous glucose insulin drip, calcium gluconate and beta
adrenergic agonist nebulization. But on reviewing literature
on thrombocytosis, we realized it to be a case of reactive
thrombocytosis with pseudohyperkalemia and the measures
were withheld.
Conclusion
Reactive thrombocytosis and pseudohyperkalemia are entities
we have to know about so that we can correctly identify them
and undue delays in providing anesthesia can be avoided.Conﬂict of interest
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